Pharmaceuticals & Healthcare Special Reports (16)
-
America's Medical Device Markets
Pub date: 21 Oct 2008 North America / United States Pharmaceuticals & Healthcare Special Report
5-year forecasts, regulatory information and company developments for 10 key medical device markets in the Americas.... Read MoreWeb Price: $490 -
Biosimilars: Obama Unfolds New Opportunities
Pub date: 06 Apr 2009 Global Pharmaceuticals & Healthcare Special Report
BMI explores challenges and opportunities in researching, developing and commercialising biosimilars, with an emphasis on regulatory issues... Read MoreWeb Price: $490 -
Blockbusters Of The Future: The Most Promising New Pharmaceuticals
Pub date: 10 May 2011 Global Pharmaceuticals & Healthcare Special Report
BMI's 2011 Pipeline Analysis focuses on the next generation of blockbuster pharmaceuticals which are currently in phase III trials, preregistration, or have been registered in the first quarter of ... Read MoreWeb Price: $490 -
Burden Of Disease Database
Pub date: 29 Sep 2008 Global / Middle East Pharmaceuticals & Healthcare Special Report
Key insights from BMIâs Burden of Disease Database, an online tool that forecasts the burden of 123 diseases in 192 countries through to 2030.... Read MoreWeb Price: $490 -
Contract Research Organisations: The Strengths And Challenges Of An Evolving Industry
Pub date: 27 Feb 2012 Global Pharmaceuticals & Healthcare Special Report
There has been strong appetite from private equity to acquire contract research organisations (CROs) throughout 2011. The spate of acquisitions comes at a time when the industry is undergoing a c... Read MoreWeb Price: $490 -
Eurozone Debt Crisis: Effects on PIIGS Pharmaceuticals Market
Pub date: 24 May 2010 Global / Middle East Pharmaceuticals & Healthcare Special Report
In this report, BMI provides an analysis of the implications of the Eurozone sovereign debt crisis on the PIIGS pharmaceutical industries, with a particular focus on the impact of the austerity measur... Read MoreWeb Price: $490 -
Frontier Pharmaceutical Markets: Underserved And Underappreciated
Pub date: 18 Jun 2009 Global Pharmaceuticals & Healthcare Special Report
Frontier pharmaceutical markets are high-risk but offer substantial returns. BMI looks at five cases studies from around the world.... Read MoreWeb Price: $490 -
Global Economic Downturn: Implications For The Pharmaceutical Industry
Pub date: 16 Sep 2009 Global / North America Pharmaceuticals & Healthcare Special Report
In this special report, BMI assess the impact of the economic downturn on drug expenditure levels in markets across the globe.... Read MoreWeb Price: $490 -
Healthcare Reform In The Emerging Markets – The New Role Of Health Insurance
Pub date: 12 May 2009 Global Pharmaceuticals & Healthcare Special Report
The World Health Organization (WHO) has been heavily involved in monitoring and advising developing nations on the logistics of reforming the healthcare sector. We note that drugmakers, medical ... Read MoreWeb Price: $490 -
Molybdenum-99: Privatising Nuclear Medicine
Pub date: 08 Jun 2011 Global Pharmaceuticals & Healthcare Special Report
This Special Report from Business Monitor International (BMI) examines the global supply of Molybdenum- 99, looking at the likelihood of price rises and the implications of investment. The report i... Read MoreWeb Price: $490 -
Neglected Tropical Diseases: New Opportunities
Pub date: 24 Sep 2009 Global Pharmaceuticals & Healthcare Special Report
Diseases can be classified as neglected when the cost of innovation, clinical trials and marketing are considered to be far more than the potential revenues. With no cost benefit, firms have not... Read MoreWeb Price: $490 -
Pharmaceutical Pricing: Dynamics In A Global Market
Pub date: 19 Apr 2010 Global Pharmaceuticals & Healthcare Special Report
BMI analyses pharmaceutical consumer price indices across 40 countries, identifying historic and likely future trends in pricing policies and dynamics.... Read MoreWeb Price: $490 -
Pharmaceutical Regulatory Convergence: The Case For A Global Agency
Pub date: 12 Jun 2009 Global Pharmaceuticals & Healthcare Special Report
Negotiating global regulatory variations is a major challenge for multinational drugmakers. Will harmonisation ease the path to commercial success?... Read MoreWeb Price: $490 -
The Opportunities Of African Healthcare: What China's Entry Means For Multinationals
Pub date: 14 Feb 2012 Global Pharmaceuticals & Healthcare Special Report
This Special Report from Business Monitor International (BMI) examines the African healthcare and pharmaceutical markets, looking at the opportunities and characteristics primarily of the sub-Sahar... Read MoreWeb Price: $490 -
The Patent Cliff: Strategies And Tactics For Survival
Pub date: 16 Sep 2009 Global Pharmaceuticals & Healthcare Special Report
The patent cliff is arguably the greatest challenge facing multinational drugmakers. In this special report, BMI outlines the strategies and tactics needed for survival.... Read MoreWeb Price: $490 -
US Regulatory Trends During 2010: A Rapidly Changing Environment
Pub date: 25 Jan 2011 Global / North America Pharmaceuticals & Healthcare Special Report
BMIâs analysis of regulatory approvals in 2010 says much about which drugmakers will outperform rivals throughout 2011, with biological blockbuster drugs leading the way.... Read MoreWeb Price: $490